21 CFR 520.2598

§ 520.2598 Trilostane.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.2598, § 520.2598 Trilostane, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87366
Permanent ID: ys:prov:87366@1
SHA-256: c24645663029cfb073ae8e41239d088c1a1fb5a13ed63002831095648663ef4c

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each capsule contains 5, 10, 20, 30, 60, or 120 milligrams (mg) trilostane. (b) Sponsor. See No. 043264 in § 510.600 of this chapter. (c) Conditions of use in dogs—(1) Amount. The starting dose is 1.0 to 3.0 milligrams per pound (2.2 to 6.7 milligrams per kilogram) once a day. (2) Indications for use. For the treatment of pituitary-dependent and adrenal-dependent hyperadrenocorticism in dogs. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.